Mesenchymal Cell News Volume 14.49 | Dec 13 2022

    0
    19








    2022-12-13 | MESCN 14.48


    Mesenchymal Cell News by STEMCELL Technologies
    Vol. 14.49 – 13 December, 2022
    TOP STORY

    Lipid-Laden Lung Mesenchymal Cells Foster Breast Cancer Metastasis via Metabolic Reprogramming of Tumor Cells and Natural Killer Cells

    In breast cancer models, researchers found lung-resident mesenchymal cells accumulating neutral lipids at the pre-metastatic stage.
    [Cell Metabolism]

    AbstractGraphical Abstract
    As a scientist, how you separate the facts from the claims is just as important as how you separate your cells. See for yourself.
    PUBLICATIONSRanked by the impact factor of the journal

    Bone ECM-Like 3D Printing Scaffold with Liquid Crystalline and Viscoelastic Microenvironment for Bone Regeneration

    Scientists developed a facile approach to fabricate a bionic scaffold perfectly combining bone extracellular matrix (ECM)-like microenvironment and robust mechanical properties.
    [ACS Nano]

    AbstractGraphical Abstract

    Aspirin Reverses Inflammatory Suppression of Chondrogenesis by Stabilizing YAP

    Investigators explored the protective role of aspirin against the negative effects of tumor necrosis factor alpha on bone marrow MSCs chondrogenesis.
    [Cell Proliferation]

    Full Article

    Supplementation of Mitochondria from Endometrial Mesenchymal Stem Cells Improves Oocyte Quality in Aged Mice

    The authors found that the mitochondria derived from endometrial MSCs could significantly improve the quality of aged oocytes.
    [Cell Proliferation]

    Full Article

    Mesenchymal Stromal Cells Donate Mitochondria to Articular Chondrocytes Exposed to Mitochondrial, Environmental, and Mechanical Stress

    Investigators demonstrated that MSCs transfer mitochondria to stressed chondrocytes in cell culture and in injured cartilage tissue.
    [Scientific Reports]

    Full Article

    cAMP Agonist Forskolin Disrupts Mitochondrial Metabolism and Induces Senescence in Human Mesenchymal Cells

    Scientists used forskolin, an adenylate cyclase agonist and cyclic adenosine monophosphate (cAMP) inducer, to disrupt metabolism in human adipose-derived MSCs and investigate the effects of metabolic dysfunction on MSC senescence.
    [Stem Cells and Development]

    Abstract

    Free Fatty Acids from Type 2 Diabetes Mellitus Serum Remodel Mesenchymal Stem Cell Lipids, Hindering Differentiation into Primordial Germ Cells

    The authors examined whether diabetic serum free fatty acids influenced the viability, differentiation, and fatty acid composition of the major lipid fractions of human adipose tissue-derived MSCs in vitro.
    [Applied Biochemistry and Biotechnology]

    AbstractGraphical Abstract

    IL-2 Delivery by Engineered Mesenchymal Stem Cells Re-invigorates CD8+ T Cells to Overcome Immunotherapy Resistance in Cancer

    To determine if exogenous interleukin-2 (IL-2) in the tumor microenvironment could overcome immune checkpoint blockade resistance, researchers engineered MSCs to successfully deliver IL-2 mutein dimer to tumor-infiltrating lymphocytes.
    [Nature Cell Biology]

    Abstract

    Combinatorial Effect of Mesenchymal Stem Cells and Extracellular Vesicles in a Hydrogel on Cartilage Regeneration

    Scientists investigated the combinatorial effect of human MSCs and extracellular vesicles on cartilage regeneration via co-encapsulation in a hyaluronic-acid-based hydrogel.
    [Journal of Tissue Engineering and Regenerative Medicine]

    Abstract
    Free E-Book: Genome Editing Applications for Disease Modeling and Cell Therapy.
    REVIEWS

    Strategies to Capitalize on Cell Spheroid Therapeutic Potential for Tissue Repair and Disease Modeling

    The authors describe the current state of preclinical spheroid research and highlight two key examples of spheroid use in clinically relevant disease modeling.
    [npj Regenerative Medicine]

    Full Article

    Stromal Cells in Prostate Cancer Pathobiology: Friends or Foes?

    Investigators discuss the main mesenchymal cell populations of the prostate stroma, highlighting their dynamic role in the transition of the healthy prostate epithelium to cancer.
    [British Journal of Cancer]

    Full Article
    INDUSTRY AND POLICY NEWS

    Calidi Biotherapeutics Receives Funding from the California Institute for Regenerative Medicine (CIRM) to Advance SuperNova-1 and NeuroNova-2 Development Programs

    Calidi Biotherapeutics, Inc. announced that the CIRM has awarded the company a $3.1 million grant to support the continued development of the company’s Supernova-1 pre-clinical program through an Investigational New Drug application.
    [Calidi Biotherapeutics, Inc.]

    Press Release
    FEATURED EVENT

    Skin-Immune Crosstalk

    February 13 – 16, 2023
    Breckenridge, Colorado, United States

    > See All Events

    JOB OPPORTUNITIES

    PhD Student – Assay Development for the AHR Signature in Dermatology

    German Cancer Research Center in the Helmholtz Association – Essen, Germany

    Postdoctoral Researcher – Cancer Biology

    Flanders Institute for Biotechnology – Leuven, Belgium

    Postdoctoral Scientist – Genomic Informatics

    University of Oxford – Oxford, England, United Kingdom

    Research Assistant – Sarcoma

    University of Texas MD Anderson Cancer Center – Houston, Texas, United States

    PhD Positions – Biomedical Sciences

    Max Delbrück Center for Molecular Medicine – Berlin-Buch, Germany

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Mesenchymal Cell News Twitter